NeuroSpan Bridge™
The world's first biomimetic nerve repair device
How It Works
The NeuroSpan Bridge™ is an investigational device designed to effectively direct nerve regeneration across the injury site, aligning nerve bundles with their intended targets. This unique approach may enable substantially improved recovery of function. Now enrolling patients, contact us to learn more about the clinical trial.
The anatomy of the peripheral nerve consists of veins/arteries, connective tissue, and individual axons bundled together in fascicles that are organized together within the nerve. The precise organization of these structures is critical for proper nerve function.
The NeuroSpan Bridge™ mimics the fascicular architecture of the nerve using microchannels. It is intended to organize regeneration so that regenerating axons remain on the same path as they bridge the injury site.
Pipeline
R&D
Preclinical Studies
FDA IDE Approval
Clinical Trial
FDA Approval
Recent News
Dec 16, 2025
Bioprinting & Tissue Engineering Devices Market PDF Report 2025-2033 | Led by North America share of 42.87% in 2024
Auxilium Biotechnologies demonstrated space‐based bioprinting on the ISS in February 2025, successfully printing eight implantable medical devices in microgravity in two hours, highlighting new manufacturing modalities...
May 22, 2025
Auxilium Biotechnologies Launches Clinical Trial for Nerve Regeneration Medical Device
Auxilium Biotechnologies, a leader in regenerative medicine, is pleased to announce the enrollment of the first patient in its clinical trial evaluating the safety and efficacy of NeuroSpan Bridge™, an innovative investigational device designed to improve nerve regeneration...
Mar 6, 2025
Ahead of Crew Return, NASA’s Crew-9 Concludes Science Mission
NASA astronaut Butch Wilmore works with hardware for InSPA Auxilium Bioprinter, a study that tests 3D printing of an implantable medical device that could facilitate recovery from peripheral nerve damage, a type of injury that can cause sensory and motor issues...
Media Inquires
Daniel Delson
Daniel@magnitude-growth.com